US Stock MarketDetailed Quotes

Biomarin Pharmaceutical (BMRN)

Watchlist

54.640
+0.540+1.00%

Close Apr 17 15:59 ET

54.640
0.0000.00%

Post 20:01 ET

10.51BMarket Cap30.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biomarin Pharmaceutical (BMRN) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

12.87%3.22B

17.03%874.57M

4.08%776.13M

15.92%825.41M

14.84%745.15M

17.97%2.85B

15.65%747.31M

28.28%745.74M

19.61%712.03M

8.79%648.83M

Operating revenue

12.87%3.22B

17.03%874.57M

4.08%776.13M

15.92%825.41M

14.84%745.15M

17.97%2.85B

15.65%747.31M

28.28%745.74M

19.61%712.03M

8.79%648.83M

Cost of revenue

23.65%717.44M

102.52%275.71M

-25.67%140.09M

15.05%150.09M

21.07%151.56M

9.05%580.24M

-1.30%136.14M

47.18%188.46M

-0.12%130.46M

-7.60%125.18M

Gross profit

10.12%2.5B

-2.02%598.86M

14.13%636.05M

16.12%675.32M

13.36%593.59M

20.48%2.27B

20.24%611.17M

22.94%557.28M

25.16%581.57M

13.60%523.65M

Operating expense

16.39%2.09B

43.07%643.46M

53.97%682.73M

-13.58%398.45M

-16.96%369.68M

5.76%1.8B

-6.49%449.76M

16.81%443.41M

15.53%461.09M

11.70%445.19M

Selling and administrative expenses

14.27%1.15B

67.37%446.2M

5.88%268.4M

-11.67%232.3M

-8.76%206.1M

13.07%1.01B

2.74%266.6M

46.87%253.5M

27.61%263M

7.05%225.9M

-Selling and marketing expense

11.22%530.2M

38.69%174.2M

20.57%131.3M

-0.57%122.1M

-14.15%102.5M

-2.40%476.7M

-5.71%125.6M

-10.66%108.9M

6.23%122.8M

--119.4M

-General and administrative expense

17.00%622.8M

92.91%272M

-5.19%137.1M

-21.40%110.2M

-2.72%103.6M

31.76%532.3M

11.64%141M

185.21%144.6M

54.91%140.2M

--106.5M

Research and development costs

23.39%921.93M

10.90%192.41M

121.46%409.48M

-12.23%161.31M

-22.57%158.73M

0.06%747.18M

-15.87%173.51M

-3.35%184.9M

3.62%183.79M

19.29%204.99M

Depreciation amortization depletion

-55.18%19.39M

-49.79%4.85M

-3.23%4.85M

-66.11%4.85M

-66.10%4.85M

-30.47%43.26M

-36.66%9.65M

-68.06%5.01M

-8.48%14.3M

-8.76%14.3M

-Depreciation and amortization

-55.18%19.39M

-49.79%4.85M

-3.23%4.85M

-66.11%4.85M

-66.10%4.85M

-30.47%43.26M

-36.66%9.65M

-68.06%5.01M

-8.48%14.3M

-8.76%14.3M

Operating profit

-13.65%409.5M

-127.63%-44.6M

-140.99%-46.68M

129.79%276.87M

185.35%223.91M

155.27%474.24M

491.46%161.41M

54.52%113.87M

83.76%120.48M

25.74%78.47M

Net non-operating interest income expense

2.87%64.01M

8.80%16.43M

1.26%15.28M

-0.39%16.15M

2.10%16.15M

51.73%62.22M

26.43%15.1M

26.12%15.09M

83.03%16.21M

91.97%15.82M

Non-operating interest income

0.03%74.9M

8.65%19.21M

-1.10%17.85M

-4.84%18.83M

-1.82%19.01M

28.36%74.88M

-2.02%17.68M

14.70%18.05M

56.87%19.79M

62.15%19.37M

Non-operating interest expense

-13.95%10.9M

7.80%2.78M

-13.11%2.58M

-25.04%2.68M

-19.28%2.86M

-26.93%12.67M

-57.74%2.58M

-21.46%2.97M

-4.82%3.57M

-4.21%3.55M

Total other finance cost

----

-34.18%391K

----

Other net income (expense)

68.74%9M

114.92%1.03M

-6.77%5.09M

206.76%4.83M

-117.34%-1.95M

113.95%5.33M

65.47%-6.87M

768.67%5.46M

-25.30%-4.53M

181.13%11.27M

Special income (charges)

--0

--10M

--0

--10M

-Less：Restructuring and merger&acquisition

----

--0

----

-Gain on sale of property,plant,equipment

--0

--10M

--0

--10M

Other non- operating income (expenses)

292.74%9M

114.92%1.03M

-6.77%5.09M

206.76%4.83M

-254.22%-1.95M

87.78%-4.67M

65.47%-6.87M

768.67%5.46M

-25.30%-4.53M

109.12%1.27M

Income before tax

-10.94%482.48M

-116.01%-27.15M

-119.58%-26.32M

125.43%297.87M

125.58%238.09M

187.31%541.76M

777.73%169.64M

222.64%134.44M

86.61%132.14M

85.96%105.55M

Income tax

16.25%133.58M

-56.55%19.42M

-84.42%4.42M

129.69%57.34M

210.35%52.4M

449.31%114.9M

4,364.89%44.7M

2,096.82%28.36M

69.00%24.96M

185.94%16.89M

Net income

-18.26%348.9M

-137.28%-46.57M

-128.98%-30.74M

124.43%240.53M

109.43%185.69M

154.62%426.86M

513.22%124.94M

162.72%106.08M

91.25%107.17M

74.35%88.66M

Net income continuous Operations

-18.26%348.9M

-137.28%-46.57M

-128.98%-30.74M

124.43%240.53M

109.43%185.69M

154.62%426.86M

513.22%124.94M

162.72%106.08M

91.25%107.17M

74.35%88.66M

Minority interest income

Net income attributable to the parent company

-18.26%348.9M

-137.28%-46.57M

-128.98%-30.74M

124.43%240.53M

109.43%185.69M

154.62%426.86M

513.22%124.94M

162.72%106.08M

91.25%107.17M

74.35%88.66M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-18.26%348.9M

-137.28%-46.57M

-128.98%-30.74M

124.43%240.53M

109.43%185.69M

154.62%426.86M

513.22%124.94M

162.72%106.08M

91.25%107.17M

74.35%88.66M

Basic earnings per share

-19.11%1.82

-136.36%-0.24

-128.57%-0.16

123.21%1.25

106.38%0.97

152.81%2.25

500.00%0.66

166.67%0.56

86.67%0.56

74.07%0.47

Diluted earnings per share

-18.55%1.8

-137.50%-0.24

-129.09%-0.16

123.64%1.23

106.52%0.95

154.02%2.21

481.82%0.64

161.90%0.55

89.66%0.55

70.37%0.46

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	12.87%3.22B	17.03%874.57M	4.08%776.13M	15.92%825.41M	14.84%745.15M	17.97%2.85B	15.65%747.31M	28.28%745.74M	19.61%712.03M	8.79%648.83M
Operating revenue	12.87%3.22B	17.03%874.57M	4.08%776.13M	15.92%825.41M	14.84%745.15M	17.97%2.85B	15.65%747.31M	28.28%745.74M	19.61%712.03M	8.79%648.83M
Cost of revenue	23.65%717.44M	102.52%275.71M	-25.67%140.09M	15.05%150.09M	21.07%151.56M	9.05%580.24M	-1.30%136.14M	47.18%188.46M	-0.12%130.46M	-7.60%125.18M
Gross profit	10.12%2.5B	-2.02%598.86M	14.13%636.05M	16.12%675.32M	13.36%593.59M	20.48%2.27B	20.24%611.17M	22.94%557.28M	25.16%581.57M	13.60%523.65M
Operating expense	16.39%2.09B	43.07%643.46M	53.97%682.73M	-13.58%398.45M	-16.96%369.68M	5.76%1.8B	-6.49%449.76M	16.81%443.41M	15.53%461.09M	11.70%445.19M
Selling and administrative expenses	14.27%1.15B	67.37%446.2M	5.88%268.4M	-11.67%232.3M	-8.76%206.1M	13.07%1.01B	2.74%266.6M	46.87%253.5M	27.61%263M	7.05%225.9M
-Selling and marketing expense	11.22%530.2M	38.69%174.2M	20.57%131.3M	-0.57%122.1M	-14.15%102.5M	-2.40%476.7M	-5.71%125.6M	-10.66%108.9M	6.23%122.8M	--119.4M
-General and administrative expense	17.00%622.8M	92.91%272M	-5.19%137.1M	-21.40%110.2M	-2.72%103.6M	31.76%532.3M	11.64%141M	185.21%144.6M	54.91%140.2M	--106.5M
Research and development costs	23.39%921.93M	10.90%192.41M	121.46%409.48M	-12.23%161.31M	-22.57%158.73M	0.06%747.18M	-15.87%173.51M	-3.35%184.9M	3.62%183.79M	19.29%204.99M
Depreciation amortization depletion	-55.18%19.39M	-49.79%4.85M	-3.23%4.85M	-66.11%4.85M	-66.10%4.85M	-30.47%43.26M	-36.66%9.65M	-68.06%5.01M	-8.48%14.3M	-8.76%14.3M
-Depreciation and amortization	-55.18%19.39M	-49.79%4.85M	-3.23%4.85M	-66.11%4.85M	-66.10%4.85M	-30.47%43.26M	-36.66%9.65M	-68.06%5.01M	-8.48%14.3M	-8.76%14.3M
Operating profit	-13.65%409.5M	-127.63%-44.6M	-140.99%-46.68M	129.79%276.87M	185.35%223.91M	155.27%474.24M	491.46%161.41M	54.52%113.87M	83.76%120.48M	25.74%78.47M
Net non-operating interest income expense	2.87%64.01M	8.80%16.43M	1.26%15.28M	-0.39%16.15M	2.10%16.15M	51.73%62.22M	26.43%15.1M	26.12%15.09M	83.03%16.21M	91.97%15.82M
Non-operating interest income	0.03%74.9M	8.65%19.21M	-1.10%17.85M	-4.84%18.83M	-1.82%19.01M	28.36%74.88M	-2.02%17.68M	14.70%18.05M	56.87%19.79M	62.15%19.37M
Non-operating interest expense	-13.95%10.9M	7.80%2.78M	-13.11%2.58M	-25.04%2.68M	-19.28%2.86M	-26.93%12.67M	-57.74%2.58M	-21.46%2.97M	-4.82%3.57M	-4.21%3.55M
Total other finance cost	----	----	----	----	----	-34.18%391K	----	----	----	----
Other net income (expense)	68.74%9M	114.92%1.03M	-6.77%5.09M	206.76%4.83M	-117.34%-1.95M	113.95%5.33M	65.47%-6.87M	768.67%5.46M	-25.30%-4.53M	181.13%11.27M
Special income (charges)	--0	--0	--0	--0	--0	--10M	--0	--0	--0	--10M
-Less：Restructuring and merger&acquisition	----	----	----	----	----	--0	----	----	----	----
-Gain on sale of property,plant,equipment	--0	--0	--0	--0	--0	--10M	--0	--0	--0	--10M
Other non- operating income (expenses)	292.74%9M	114.92%1.03M	-6.77%5.09M	206.76%4.83M	-254.22%-1.95M	87.78%-4.67M	65.47%-6.87M	768.67%5.46M	-25.30%-4.53M	109.12%1.27M
Income before tax	-10.94%482.48M	-116.01%-27.15M	-119.58%-26.32M	125.43%297.87M	125.58%238.09M	187.31%541.76M	777.73%169.64M	222.64%134.44M	86.61%132.14M	85.96%105.55M
Income tax	16.25%133.58M	-56.55%19.42M	-84.42%4.42M	129.69%57.34M	210.35%52.4M	449.31%114.9M	4,364.89%44.7M	2,096.82%28.36M	69.00%24.96M	185.94%16.89M
Net income	-18.26%348.9M	-137.28%-46.57M	-128.98%-30.74M	124.43%240.53M	109.43%185.69M	154.62%426.86M	513.22%124.94M	162.72%106.08M	91.25%107.17M	74.35%88.66M
Net income continuous Operations	-18.26%348.9M	-137.28%-46.57M	-128.98%-30.74M	124.43%240.53M	109.43%185.69M	154.62%426.86M	513.22%124.94M	162.72%106.08M	91.25%107.17M	74.35%88.66M
Minority interest income
Net income attributable to the parent company	-18.26%348.9M	-137.28%-46.57M	-128.98%-30.74M	124.43%240.53M	109.43%185.69M	154.62%426.86M	513.22%124.94M	162.72%106.08M	91.25%107.17M	74.35%88.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-18.26%348.9M	-137.28%-46.57M	-128.98%-30.74M	124.43%240.53M	109.43%185.69M	154.62%426.86M	513.22%124.94M	162.72%106.08M	91.25%107.17M	74.35%88.66M
Basic earnings per share	-19.11%1.82	-136.36%-0.24	-128.57%-0.16	123.21%1.25	106.38%0.97	152.81%2.25	500.00%0.66	166.67%0.56	86.67%0.56	74.07%0.47
Diluted earnings per share	-18.55%1.8	-137.50%-0.24	-129.09%-0.16	123.64%1.23	106.52%0.95	154.02%2.21	481.82%0.64	161.90%0.55	89.66%0.55	70.37%0.46
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm